Livzon Pharmaceutical Group Inc.

SZSE:000513 Stock Report

Market Cap: CN¥31.4b

Livzon Pharmaceutical Group Management

Management criteria checks 4/4

Livzon Pharmaceutical Group's CEO is Yanggang Tang, appointed in Dec 2018, has a tenure of 5.33 years. total yearly compensation is CN¥581.00K, comprised of 19.1% salary and 80.9% bonuses, including company stock and options. directly owns 0.037% of the company’s shares, worth CN¥11.76M. The average tenure of the management team and the board of directors is 9.8 years and 4.8 years respectively.

Key information

Yanggang Tang

Chief executive officer

CN¥581.0k

Total compensation

CEO salary percentage19.1%
CEO tenure5.3yrs
CEO ownership0.04%
Management average tenure9.8yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Livzon Pharmaceutical Group Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Apr 26
Livzon Pharmaceutical Group Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Does Livzon Pharmaceutical Group (SZSE:000513) Have A Healthy Balance Sheet?

Apr 21
Does Livzon Pharmaceutical Group (SZSE:000513) Have A Healthy Balance Sheet?

Is Now The Time To Put Livzon Pharmaceutical Group (SZSE:000513) On Your Watchlist?

Mar 15
Is Now The Time To Put Livzon Pharmaceutical Group (SZSE:000513) On Your Watchlist?

CEO Compensation Analysis

How has Yanggang Tang's remuneration changed compared to Livzon Pharmaceutical Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

CN¥2b

Dec 31 2023CN¥581kCN¥111k

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥2b

Dec 31 2022CN¥520kn/a

CN¥2b

Sep 30 2022n/an/a

CN¥2b

Jun 30 2022n/an/a

CN¥2b

Mar 31 2022n/an/a

CN¥2b

Jan 01 2022n/an/a

CN¥2b

Sep 30 2021n/an/a

CN¥2b

Jun 30 2021n/an/a

CN¥2b

Mar 31 2021n/an/a

CN¥2b

Jan 01 2021n/an/a

CN¥2b

Sep 30 2020n/an/a

CN¥2b

Jun 30 2020n/an/a

CN¥2b

Mar 31 2020n/an/a

CN¥1b

Jan 01 2020n/an/a

CN¥1b

Sep 30 2019n/an/a

CN¥1b

Jun 30 2019n/an/a

CN¥1b

Mar 31 2019n/an/a

CN¥1b

Dec 31 2018CN¥3mCN¥800k

CN¥1b

Compensation vs Market: Yanggang's total compensation ($USD80.18K) is below average for companies of similar size in the CN market ($USD209.05K).

Compensation vs Earnings: Yanggang's compensation has been consistent with company performance over the past year.

CEO

Yanggang Tang (53 yo)

5.3yrs

Tenure

CN¥581,000

Compensation

Mr. Yanggang Tang has been President of Livzon Pharmaceutical Group since December 28, 2018 and serves as its Executive Director since February 14, 2019 and served as its Executive Vice President from July...

Leadership Team

NamePositionTenureCompensationOwnership
Yanggang Tang
President & Executive Director5.3yrsCN¥581.00k0.037%
CN¥ 11.8m
Guoxiang Xu
Executive Vice Chairman & VP of Sales6.8yrsCN¥547.19k0.085%
CN¥ 26.7m
Yanxia Si
VP & CFO9.8yrsCN¥354.39k0.044%
CN¥ 13.8m
Liang Yang
VP, Secretary to the Board & Company Secretary9.8yrsCN¥235.72k0.022%
CN¥ 6.9m
Daihong Yang
Vice President17.9yrsCN¥371.99k0.051%
CN¥ 16.0m
Yuxuan Huang
Vice President5.5yrsCN¥239.24k0.015%
CN¥ 4.6m
Jun Du
Vice Presidentless than a yearCN¥516.55k0.0054%
CN¥ 1.7m
Jianing Liu
Chief Investment Officer & Head of BD Dept.no datano datano data
Jianying Zhuang
Head of Accounting Departmentno datano datano data
Maolin Wang
Chief Supervisor and GM of Legal & Compliance23.3yrsCN¥281.00kno data
Daping Liu
Vice Presidentless than a yearno datano data

9.8yrs

Average Tenure

55yo

Average Age

Experienced Management: 000513's management team is seasoned and experienced (9.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yanggang Tang
President & Executive Director5.2yrsCN¥581.00k0.037%
CN¥ 11.8m
Guoxiang Xu
Executive Vice Chairman & VP of Sales6.8yrsCN¥547.19k0.085%
CN¥ 26.7m
Maolin Wang
Chief Supervisor and GM of Legal & Compliance14.3yrsCN¥281.00kno data
Qingfeng Qiu
Non-Executive Director17yrsCN¥9.60kno data
Baoguo Zhu
Non-Executive Chairman of the Board21.8yrsCN¥325.00k0%
CN¥ 0
Desheng Tao
Non-Executive Vice Chairman14.8yrsCN¥300.00k0.080%
CN¥ 25.0m
Xiong Yu
Non-Executive Director3.8yrsCN¥9.60kno data
Qiusheng Tian
Independent Non-Executive Director4.5yrsCN¥12.00kno data
Hua Bai
Independent Non-Executive Director3.8yrsCN¥12.00kno data
Huiyuan Luo
Independent Non-Executive Director2.8yrsCN¥12.00kno data
Kam Wa Wong
Independent Non-Executive Director4.5yrsCN¥12.00kno data
Lijie Cui
Independent Non-Executive Director2.8yrsCN¥12.00kno data

4.8yrs

Average Tenure

57yo

Average Age

Experienced Board: 000513's board of directors are considered experienced (4.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.